Metagame

Pharma deal flow collapsed 62 percent while AI startups hide in plain sight

8 min · 19. maj 2026
episode Pharma deal flow collapsed 62 percent while AI startups hide in plain sight cover

Description

Pharma deal flow didn't collapse 62.5 percent last quarter — it just stopped filing as pharma. AI-native drug discovery companies like Recursion and Insitro are filing under "Other Technology" because their value lives in computational platforms, not clinical pipelines, which means healthcare funds tracking SEC codes are literally missing deals before they hit the committee. Total healthcare-adjacent deal count stayed completely flat at 74 deals, but if your allocation strategy runs on sector labels instead of manual tagging, you're benchmarking against a category that no longer describes where the actual capital is flowing.

Comments

0

Be the first to comment

Sign up now and become a member of the Metagame community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

43 episodes